169 related articles for article (PubMed ID: 30870280)
1. Hysterectomy Practice Patterns in the Postmorcellation Era.
Jorgensen EM; Modest AM; Hur HC; Hacker MR; Awtrey CS
Obstet Gynecol; 2019 Apr; 133(4):643-649. PubMed ID: 30870280
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic Hysterectomy Route, Resource Use, and Outcomes: Change After Power Morcellation Warning.
Desai VB; Wright JD; Lin H; Gross CP; Sallah YH; Schwartz PE; Xu X
Obstet Gynecol; 2019 Aug; 134(2):227-238. PubMed ID: 31348209
[TBL] [Abstract][Full Text] [Related]
3. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.
Harris JA; Swenson CW; Uppal S; Kamdar N; Mahnert N; As-Sanie S; Morgan DM
Am J Obstet Gynecol; 2016 Jan; 214(1):98.e1-98.e13. PubMed ID: 26314519
[TBL] [Abstract][Full Text] [Related]
4. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation.
Multinu F; Casarin J; Hanson KT; Angioni S; Mariani A; Habermann EB; Laughlin-Tommaso SK
JAMA Surg; 2018 Jun; 153(6):e180141. PubMed ID: 29641835
[TBL] [Abstract][Full Text] [Related]
5. Association of the U.S. Food and Drug Administration Morcellation Warning With Rates of Minimally Invasive Hysterectomy and Myomectomy.
Barron KI; Richard T; Robinson PS; Lamvu G
Obstet Gynecol; 2015 Dec; 126(6):1174-1180. PubMed ID: 26595561
[TBL] [Abstract][Full Text] [Related]
6. Hospital variation in responses to safety warnings about power morcellation in hysterectomy.
Xu X; Desai VB; Wright JD; Lin H; Schwartz PE; Gross CP
Am J Obstet Gynecol; 2021 Jun; 224(6):589.e1-589.e13. PubMed ID: 33359176
[TBL] [Abstract][Full Text] [Related]
7. Change in Surgical Practice for Women With Leiomyomas After the U.S. Food and Drug Administration Morcellator Safety Communication.
Clark NM; Schembri M; Jacoby VL
Obstet Gynecol; 2017 Nov; 130(5):1057-1063. PubMed ID: 29016511
[TBL] [Abstract][Full Text] [Related]
8. Minimally Invasive Hysterectomy and Power Morcellation Trends in a West Coast Integrated Health System.
Zaritsky E; Tucker LY; Neugebauer R; Chou T; Flanagan T; Walter AJ; Raine-Bennett T
Obstet Gynecol; 2017 Jun; 129(6):996-1005. PubMed ID: 28486359
[TBL] [Abstract][Full Text] [Related]
9. Impact of the 2014 Food and Drug Administration Warnings Against Power Morcellation.
Lum DA; Sokol ER; Berek JS; Schulkin J; Chen L; McElwain CA; Wright JD
J Minim Invasive Gynecol; 2016; 23(4):548-56. PubMed ID: 26827905
[TBL] [Abstract][Full Text] [Related]
10. Impact of power morcellator removal on hysterectomy practice patterns.
Wesol A; Woolley S
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():41-44. PubMed ID: 28599164
[TBL] [Abstract][Full Text] [Related]
11. Trends in Mode of Hysterectomy After the U.S. Food and Drug Administration Power Morcellation Advisory.
Ottarsdottir H; Cohen SL; Cox M; Vitonis A; Einarsson JI
Obstet Gynecol; 2017 Jun; 129(6):1014-1021. PubMed ID: 28486371
[TBL] [Abstract][Full Text] [Related]
12. Complication rate of uterine morcellation in laparoscopic supracervical hysterectomy: a retrospective cohort study.
Smits RM; De Kruif JH; Van Heteren CF
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():179-82. PubMed ID: 26943477
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Morcellation Techniques at the Time of Laparoscopic Hysterectomy and Myomectomy.
Meurs EAIM; Brito LG; Ajao MO; Goggins ER; Vitonis AF; Einarsson JI; Cohen SL
J Minim Invasive Gynecol; 2017; 24(5):843-849. PubMed ID: 28483536
[TBL] [Abstract][Full Text] [Related]
14. Containment Bag Use Among Women Who Undergo Hysterectomy With Laparoscopic Power Morcellation.
Wright JD; Chen L; Melamed A; Clair CMS; Hou JY; Khoury-Collado F; Gockley A; Accordino M; Hershman DL; Xu X
Obstet Gynecol; 2022 Sep; 140(3):371-380. PubMed ID: 35926199
[TBL] [Abstract][Full Text] [Related]
15. Racial Disparities in Response to a US Food and Drug Administration Safety Communication Regarding the Use of Power Morcellation for the Treatment of Uterine Leiomyoma.
Matsushita T; Sekizawa A; Jacobs LK
J Minim Invasive Gynecol; 2020 Jan; 27(1):178-185.e1. PubMed ID: 30936031
[TBL] [Abstract][Full Text] [Related]
16. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
17. Current Issues with Hysterectomy.
Barker MA
Obstet Gynecol Clin North Am; 2016 Sep; 43(3):591-601. PubMed ID: 27521886
[TBL] [Abstract][Full Text] [Related]
18. Reduced Complications Following Implementation of Laparoscopic Hysterectomy: A Danish Population-based Cohort Study of Minimally Invasive Benign Gynecologic Surgery between 2004 and 2018.
Settnes A; Topsoee MF; Moeller C; Dueholm M; Kopp TI; Norrbom C; Rasmussen SC; Froeslev PA; Joergensen A; Dreisler E; Gimbel H
J Minim Invasive Gynecol; 2020; 27(6):1344-1353.e3. PubMed ID: 31740432
[TBL] [Abstract][Full Text] [Related]
19. Trends in Use and Outcomes of Women Undergoing Hysterectomy With Electric Power Morcellation.
Wright JD; Chen L; Burke WM; Hou JY; Tergas AI; Ananth CV; Hershman DL
JAMA; 2016 Aug 23-30; 316(8):877-8. PubMed ID: 27552622
[No Abstract] [Full Text] [Related]
20. The Surgical Approach to Abdominal Sacrocolpopexy and Concurrent Hysterectomy: Trends for the Past Decade.
Winkelman WD; Modest AM; Richardson ML
Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e196-e201. PubMed ID: 32412972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
